Mangalam Drugs & Organics Ltd

MANGALAM

Company Profile

  • Business description

    Mangalam Drugs & Organics Ltd commenced its manufacturing of Active Pharmaceutical Ingredients (APIs) and intermediates. The company is engaged in the manufacture and sale of APIs for various therapeutic segments, including anti-malaria, anti-retroviral, and anti-hypertensive. It is approved by the Bill Clinton Foundation. The company is actively producing Pyronaridine Tetraphosphate, a new API used in antimalarial treatments. The company has received prequalification from the World Health Organization (WHO) for both micronized and non-micronized forms of Pyronaridine Phosphate.

  • Contact

    P. D'Mello Road
    Rupam Building, 3rd Floor, No. 239
    Near General Post Office
    MumbaiMH400001
    IND

    T: +91 2222616200

    https://www.mangalamdrugs.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 March 2026

    Employees

    480

Stocks News & Analysis

stocks

2 ASX shares that benefit from sticky inflation

Inflation is a key risk to shareholders. Here’s why these two ASX shares benefit from higher inflation.
stocks

Our view of Dexus / Scentre deal

Dexus acquires stake in Westfiend Chermside.
stocks

Undervalued ASX retailer benefiting from rebound in spending

Uplift in sales momentum continues.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,923.807.50-0.08%
CAC 408,152.1283.501.03%
DAX 4024,281.6095.110.39%
Dow JONES (US)48,458.05245.96-0.51%
FTSE 1009,740.7791.740.95%
HKSE25,628.88347.91-1.34%
NASDAQ23,195.17398.69-1.69%
Nikkei 22550,168.11668.44-1.31%
NZX 50 Index13,408.141.230.01%
S&P 5006,827.4173.59-1.07%
S&P/ASX 2008,635.008.90-0.10%
SSE Composite Index3,867.9221.42-0.55%

Market Movers